May 3, 2026 Surf Air Mobility Announces $15 Million Registered Direct Offering of Common Stock And New $15 Million Asset-Backed Loan
May 3, 2026 Emerging Data for Lantern Pharma’s Investigational Drug LP-300 Demonstrates 8.3-Month Median Progression-Free Survival in Patients with EGFR L858R Lung Cancer After Targeted Therapy Failure — With No Added Toxicity
May 3, 2026 Motorola Solutions Redefines Crime Center Operations, Centering Workflows Around Measurable “Missions”
